AKT1 and neoplasm: Interestingly, AKT phosphorylation was induced at the tumour–stroma interface of invasive atorvastatin-treated tumours (Fig. S5), suggesting that tumour–stroma interactions contribute to re-activation of RAS downstream pathways as previously reported (Kruspig et al., 2018), leading to histopathological progression.